Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection
Lisa M Chirch, Roy T SteigbigelDivision of Infectious Diseases, Department of Medicine, Stony Brook University Medical Center, Stony Brook, New York, USAAbstract: Raltegravir, an inhibitor of the HIV-1 integrase enzyme, is the first available agent in a new class of antiretroviral drugs. Raltegravir...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-04-01
|
| Series: | Infection and Drug Resistance |
| Online Access: | http://www.dovepress.com/raltegravir-in-combination-with-other-antiretroviral-agents-for-the-tr-a4315 |